MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_ocn994499908
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |||||||||||
008 110623s2010 nyua ob 001 0 eng
010 |a  2020685863 
040 |a DLC  |b eng  |e rda  |c DLC  |d XFH  |d OCLCO  |d OCLCF  |d OCLCQ  |d YDXCP  |d N$T  |d E7B  |d EBLCP  |d AZK  |d AGLDB  |d ICA  |d MOR  |d PIFAG  |d MERUC  |d ZCU  |d U3W  |d D6H  |d STF  |d WRM  |d VTS  |d COCUF  |d NRAMU  |d ICG  |d VT2  |d AU@  |d WYU  |d DKC  |d M8D  |d UX1  |d UKCRE  |d AJS  |d OCLCO 
019 |a 834603828  |a 923663526  |a 961567277  |a 962706178  |a 988413068  |a 992078116  |a 1037943029  |a 1038655284  |a 1045498585  |a 1055373088  |a 1066439045  |a 1081218319  |a 1153527275  |a 1181910281  |a 1259265509 
020 |a 9781616684433  |q ebook 
020 |a 1616684437 
020 |z 9781616683214 
020 |z 161668321X 
029 1 |a AU@  |b 000069242245 
029 1 |a AU@  |b 000053299555 
029 1 |a DEBBG  |b BV043961434 
029 1 |a DEBBG  |b BV044088808 
029 1 |a DEBSZ  |b 481300341 
029 1 |a NZ1  |b 15347071 
035 |a (OCoLC)994499908  |z (OCoLC)834603828  |z (OCoLC)923663526  |z (OCoLC)961567277  |z (OCoLC)962706178  |z (OCoLC)988413068  |z (OCoLC)992078116  |z (OCoLC)1037943029  |z (OCoLC)1038655284  |z (OCoLC)1045498585  |z (OCoLC)1055373088  |z (OCoLC)1066439045  |z (OCoLC)1081218319  |z (OCoLC)1153527275  |z (OCoLC)1181910281  |z (OCoLC)1259265509 
050 0 0 |a RE320 
060 0 0 |a 2011 A-625 
060 1 0 |a WW 212 
072 7 |a HEA  |x 037000  |2 bisacsh 
072 7 |a MED  |x 063000  |2 bisacsh 
082 0 4 |a 617.773  |q OCoLC  |2 23/eng/20230216 
049 |a UAMI 
245 0 0 |a Conjunctivitis :  |b symptoms, treatment, and prevention /  |c Anna R. Sallinger, editor. 
264 1 |a New York :  |b Nova Biomedical Books,  |c [2010] 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Eye and vision research developments 
504 |a Includes bibliographical references and index. 
588 |a Description based on print version record. 
546 |a English. 
505 0 |a CONJUNCTIVITIS: SYMPTOMS, TREATMENT AND PREVENTION ; CONTENTS ; PREFACE ; ALLERGIC DISORDERS OF THE CONJUNCTIVA ; ABSTRACT ; 1. INTRODUCTION ; 2. IMMUNOLOGY RELEVANT TO ALLERGIC EYE DISEASE ; 2.1. Introduction ; 2.2. Lymphocyte Activation ; 2.3. Immune Hypersensitivity Reaction in Allergic Eye Diseases ; 2.3.1. Antibody-Mediated Hypersensitivity in Allergic Eye Diseases ; 2.3.1.1. IgG-Mediated Hypersensitivity Immune Reactions ; 2.3.1.2. IgE-Mediated Hypersensitivity Immune Reactions ; 2.3.2. T-Lymphocite-Mediated Hypersensitivity in Allergic Eye Diseases. 
505 8 |a 3. CELLS AND MEDIATORS IN ALLERGIC EYE DISEASE 3.1. Antigen ; 3.2. Antibodies ; 3.3. B Lymphocytes ; 3.4. Antigen Presenting Cells ; 3.5. Dendritic Cells ; 3.6. Major histocomapibility complex (MHC) ; 3.7. Tryptase ; 3.8. Histamine ; 3.9. Langerhans Cells (LC) ; 3.10. Mast Cells ; 3.11. Prostaglandins ; 3.12. Leukotrienes ; 3.13. Adhesion Molecules ; 3.14. Neutrophils ; 3.15. Complement ; 3.16. Matrix Metalloproteinases (MMP) ; 3.17. Growth Factors ; 3.18. Eosinophils ; 3.19. Epithelial Cells ; 3.20. Fibroblast ; 3.21. T-Lymphocytes. 
505 8 |a 3.22. Co-Stimulatory Molecules and Receptors 3.24. Chemokines ; 4. PHARMACOLOGIC THERAPY OF ALLERGIC EYE DISEASE ; 4.1. Vasoconstrictors ; 4.2. Antihistamines ; 4.3. Mast Cell Stabilizers ; 4.4. Multimodal or Dual Acting Agents ; 4.5. Nonsteroidal Anti-Inflammatory Drugs (NSAID) ; 4.6. Steroids ; 4.7. Anti-Metabolites ; 4.8. Immunomodulators ; 5. SPECIFIC ALLERGIC EYE DISEASES ; 5.1. Allergic conjunctivitis ; 5.2. Vernal Keratoconjunctivitis ; 5.3. Giant Papillary Conjunctivitis ; 5.4. Atopic Keratoconjunctivitis ; 5.5. Contact Ocular Allergy ; CONCLUSION. 
505 8 |a ACKNOWLEDGMENT REFERENCES ; NOVEL DRUG DELIVERY APPROACHES IN DRY EYE SYNDROME THERAPY ; ABSTRACT ; ABBREVIATIONS ; 1. INTRODUCTION ; 2. LACHRYMAL FUNCTIONAL UNIT AND DRY EYE SYNDROME ; 2.1. Causes of the Dry Eye ; 2.2. Signs and Symptoms of the Dry Eye ; 3. THERAPEUTIC APPROACHES OF THE DRY EYE SYNDROME ; 3.1. Current Therapeutic Strategies ; 3.1.1. Tear Substitution: Artificial Tear Substitutes and Lubricants ; 3.1.2. Tear Preservation ; 3.1.2.1. Occlusion of the Tear Drainage System ; 3.1.2.2. Other Methods of Tear Preservation ; 3.1.3. Pharmacological Stimulation of Natural Tears. 
505 8 |a 3.1.4. Treatment of the Underlying Causes of Dry Eye Disease 3.1.4.1. Cyclosporine A ; 3.1.4.2. Topical Corticosteroids ; 3.1.4.3. Non-steroidal Anti-inflammatory Drugs (NSAIDs) ; 3.1.4.4. Systemic Tetracyclines ; 3.1.4.5. Sexual Hormones ; 3.1.4.6. Topical Vitamin A ; 3.1.4.7. Topical Autologous Serum ; 3.1.4.8. Omega-6; 3.1.4.9. Botulinum Toxin A ; 3.1.4.10. Acupuncture ; 3.1.4.11. Antiviral Agents ; 3.2. Novel Therapeutic Strategies ; 3.2.1. Polymeric Nanoparticles ; 3.2.1.1. Natural Polymers ; 3.2.1.2. Polymeric Coating of Various Carrier Systems ; 3.2.2. Solid Lipid Nanoparticles. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Conjunctivitis  |x Diagnosis. 
650 0 |a Conjunctivitis  |x Prevention. 
650 0 |a Conjunctivitis  |x Treatment. 
650 0 |a Conjunctiva  |x Diseases. 
650 0 |a Eye  |x Diseases. 
650 0 |a Diseases. 
650 0 |a Conjunctivitis. 
650 2 |a Conjunctival Diseases 
650 2 |a Eye Diseases 
650 2 |a Disease 
650 2 |a Conjunctivitis 
650 6 |a Conjonctivite  |x Traitement. 
650 6 |a Conjonctive  |x Maladies. 
650 6 |a Œil  |x Maladies. 
650 6 |a Maladies. 
650 6 |a Conjonctivite. 
650 7 |a illness.  |2 aat 
650 7 |a disease.  |2 aat 
650 7 |a HEALTH & FITNESS  |x Vision.  |2 bisacsh 
650 7 |a MEDICAL  |x Ophthalmology.  |2 bisacsh 
650 7 |a Conjunctiva  |x Diseases  |2 fast 
650 7 |a Conjunctivitis  |2 fast 
650 7 |a Diseases  |2 fast 
650 7 |a Eye  |x Diseases  |2 fast 
700 1 |a Sallinger, Anna R. 
776 0 8 |i Print version:  |t Conjunctivitis  |d New York : Nova Biomedical Books, [2010]  |z 9781616683214  |w (DLC) 2011414786 
830 0 |a Eye and vision research developments series. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540304  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3020407 
938 |a ebrary  |b EBRY  |n ebr10676697 
938 |a EBSCOhost  |b EBSC  |n 540304 
938 |a YBP Library Services  |b YANK  |n 10373197 
994 |a 92  |b IZTAP